Reduced response of prostate cancer cells to TRAIL is modulated by NFκB-mediated inhibition of caspases and Bid activation

  • Authors:
    • Manal A. Eid
    • Ronald W. Lewis
    • Asim B. Abdel-Mageed
    • M. Vijay Kumar
  • View Affiliations

  • Published online on: July 1, 2002     https://doi.org/10.3892/ijo.21.1.111
  • Pages: 111-117
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We describe the effects of tumor necrosis factor α-related apoptosis inducing ligand (TRAIL) on the induction of apoptosis in two related prostate cancer cell lines, PC3AR and PC3Neo. TRAIL is a potent drug, which induces apoptosis preferentially in cancer cells. Treatment of prostate cancer cells, reduced survival by ~41% in PC3AR, but only ~18% PC3Neo were killed. Western analysis demonstrated that increased apoptotic response of PC3AR cells may be due to differential response of death receptors DR4, DR5 and decoy receptors DcR1 and DcR2. Caspases-8, -9, -3 and Bid were highly activated in PC3AR cells compared to PC3Neo. Furthermore, lower apoptotic response of PC3Neo was probably due to higher expression of NFκB. Blocking the function of NFκB by adenoviral infection of mutated IκB, increased apoptotic response confirming the influence of NFκB. Thus, we have demonstrated the role of NFκB in the differential response of prostate cancer cells to TRAIL.

Related Articles

Journal Cover

July 2002
Volume 21 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Eid MA, Lewis RW, Abdel-Mageed AB and Kumar MV: Reduced response of prostate cancer cells to TRAIL is modulated by NFκB-mediated inhibition of caspases and Bid activation. Int J Oncol 21: 111-117, 2002
APA
Eid, M.A., Lewis, R.W., Abdel-Mageed, A.B., & Kumar, M.V. (2002). Reduced response of prostate cancer cells to TRAIL is modulated by NFκB-mediated inhibition of caspases and Bid activation. International Journal of Oncology, 21, 111-117. https://doi.org/10.3892/ijo.21.1.111
MLA
Eid, M. A., Lewis, R. W., Abdel-Mageed, A. B., Kumar, M. V."Reduced response of prostate cancer cells to TRAIL is modulated by NFκB-mediated inhibition of caspases and Bid activation". International Journal of Oncology 21.1 (2002): 111-117.
Chicago
Eid, M. A., Lewis, R. W., Abdel-Mageed, A. B., Kumar, M. V."Reduced response of prostate cancer cells to TRAIL is modulated by NFκB-mediated inhibition of caspases and Bid activation". International Journal of Oncology 21, no. 1 (2002): 111-117. https://doi.org/10.3892/ijo.21.1.111